Temple Acquires LongeVus to Bolster Wearable Tech Validation
Temple, led by Deepinder Goyal, acquires LongeVus to enhance its wearable tech validation efforts.
Temple, a wearable technology startup founded by Deepinder Goyal, has acquired London-based longevity clinic LongeVus. This move aims to strengthen Temple's scientific and clinical capabilities as it prepares for a broader product launch. Financial specifics of the acquisition remain undisclosed.
Strategic Integration of Expertise
With this acquisition, LongeVus founders Robert Mohr and Avi Roy will join Temple's leadership team. Mohr is set to become the Chief Medical Officer, while Roy will assume the role of Head of Science. Despite the acquisition, LongeVus will continue its operations, serving its existing clientele under the Temple umbrella.
This collaboration comes at a critical time for Temple as it seeks to validate the science behind its innovative wearable device. The device, designed to be worn on the temple, monitors physiological signals and utilizes an 'Entropy' metric for data analysis. Over the past two months, Mohr and Roy have been testing the device and collaborating with Temple’s scientists to refine its data accuracy.
Advancing Wearable Tech Validation
Temple's efforts to validate its sensor technology are ongoing, with a focus on obtaining peer-reviewed validation of its studies. The company has spent approximately two years developing this technology and building the scientific foundation necessary for its upcoming product launch.
The acquisition of LongeVus is a strategic step for Temple to enhance its scientific validation processes. Goyal highlighted that the expertise of Mohr and Roy is invaluable in ensuring the device's effectiveness and reliability.
Building on Recent Success
Earlier this year, Temple gained public attention after securing $54 million in funding, raising its valuation to around $190 million. The funding round included investments from Peak XV Partners, Steadview Capital, Dharana Capital, and Info Edge Ventures, along with several startup founders and early investors of Zomato. In May, Goyal announced that the first batch of 100 Temple devices was ready for shipment to selected users such as athletes and scientists for feedback.
Deepinder Goyal, who previously stepped down as CEO of Zomato's parent company Eternal, remains engaged with Temple as he pursues innovative ventures in wearable technology. He continues to serve as vice-chairman of Eternal, focusing on high-risk, experimental projects.